Adjuvia Therapeutics https://validator.w3.org/feed/docs/rss2.html Homepage Adjuvia Therapeutics Initiates Phase 1 Clinical Trial of ATI-105 for Friedreich’s Ataxia Science Pipeline Our Story Partnering Contact Us Opt-out preferences Privacy Statement (US) Adjuvia Therapeutics closes $8 million Series Seed financing to advance novel mitochondrial disease therapy into the clinic